Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Alzheimer's Disease

  Free Subscription


Articles published in Exp Gerontol

Retrieve available abstracts of 35 articles:
HTML format
Text format



Single Articles


    July 2018
  1. TOROSYAN N, Sethanandha C, Grill JD, Dilley ML, et al
    Changes in regional cerebral blood flow associated with a 45day course of the ketogenic agent, caprylidene, in patients with mild to moderate Alzheimer's disease: Results of a randomized, double-blinded, pilot study.
    Exp Gerontol. 2018;111:118-121.
    PubMed     Text format     Abstract available


    June 2018
  2. SHEKHAR S, Yadav Y, Singh AP, Pradhan R, et al
    Neuroprotection by ethanolic extract of Syzygium aromaticum in Alzheimer's disease like pathology via maintaining oxidative balance through SIRT1 pathway.
    Exp Gerontol. 2018 Jun 27. pii: S0531-5565(18)30302.
    PubMed     Text format     Abstract available


  3. BUFFA R, Mereu E, Putzu P, Mereu RM, et al
    Corrigendum to "Lower lean mass and higher percent fat mass in patients with Alzheimer's disease" [Exp. Gerontol. 58 (2014) 30-33].
    Exp Gerontol. 2018 Jun 2. pii: S0531-5565(18)30330.
    PubMed     Text format    


    March 2018
  4. KUNUTSOR SK, Laukkanen JA, Burgess S
    Genetically elevated gamma-glutamyltransferase and Alzheimer's disease.
    Exp Gerontol. 2018 Mar 2. pii: S0531-5565(18)30042.
    PubMed     Text format     Abstract available


    January 2018
  5. HENRIQUES AD, Benedet AL, Camargos EF, Rosa-Neto P, et al
    Fluid and imaging biomarkers for Alzheimer's disease: Where we stand and where to head to.
    Exp Gerontol. 2018 Jan 4. pii: S0531-5565(17)30411.
    PubMed     Text format     Abstract available


    December 2017
  6. LE PAGE A, Dupuis G, Frost EH, Larbi A, et al
    Role of the peripheral innate immune system in the development of Alzheimer's disease.
    Exp Gerontol. 2017 Dec 21. pii: S0531-5565(17)30541.
    PubMed     Text format     Abstract available


    November 2017
  7. MEREU E, Succa V, Buffa R, Sanna C, et al
    Total body and arm bioimpedance in patients with Alzheimer's disease.
    Exp Gerontol. 2017 Nov 21. pii: S0531-5565(17)30668.
    PubMed     Text format     Abstract available


    October 2017
  8. YASHIN AI, Fang F, Kovtun M, Wu D, et al
    Hidden heterogeneity in Alzheimer's disease: Insights from genetic association studies and other analyses.
    Exp Gerontol. 2017 Oct 26. pii: S0531-5565(17)30424.
    PubMed     Text format     Abstract available


  9. MATHYS J, Gholamrezaee M, Henry H, von Gunten A, et al
    Decreasing body mass index is associated with cerebrospinal fluid markers of Alzheimer's pathology in MCI and mild dementia.
    Exp Gerontol. 2017 Oct 17. pii: S0531-5565(17)30465.
    PubMed     Text format     Abstract available


  10. FARINA N, Jerneren F, Turner C, Hart K, et al
    Homocysteine concentrations in the cognitive progression of Alzheimer's disease.
    Exp Gerontol. 2017 Oct 9. pii: S0531-5565(17)30374.
    PubMed     Text format     Abstract available


    August 2017
  11. SCARABINO D, Broggio E, Gambina G, Corbo RM, et al
    Leukocyte telomere length in mild cognitive impairment and Alzheimer's disease patients.
    Exp Gerontol. 2017 Aug 18. pii: S0531-5565(17)30445.
    PubMed     Text format     Abstract available


    July 2017
  12. CROTEAU E, Castellano CA, Fortier M, Bocti C, et al
    A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer's disease.
    Exp Gerontol. 2017 Jul 11. pii: S0531-5565(17)30228.
    PubMed     Text format     Abstract available


    May 2017
  13. KWON Y
    Luteolin as a potential preventive and therapeutic candidate for Alzheimer's disease.
    Exp Gerontol. 2017 May 17. pii: S0531-5565(17)30214.
    PubMed     Text format     Abstract available


    March 2017
  14. LI J, Cui X, Ma X, Wang Z, et al
    rBTI reduced beta-amyloid-induced toxicity by promoting autophagy-lysosomal degradation via DAF-16 in Caenorhabditis elegans.
    Exp Gerontol. 2017;89:78-86.
    PubMed     Text format     Abstract available


    February 2017
  15. HUANG M, Jiang X, Liang Y, Liu Q, et al
    Berberine improves cognitive impairment by promoting autophagic clearance and inhibiting production of beta-amyloid in APP/tau/PS1 mouse model of Alzheimer's disease.
    Exp Gerontol. 2017;91:25-33.
    PubMed     Text format     Abstract available


  16. MACKLIN L, Griffith CM, Cai Y, Rose GM, et al
    Glucose tolerance and insulin sensitivity are impaired in APP/PS1 transgenic mice prior to amyloid plaque pathogenesis and cognitive decline.
    Exp Gerontol. 2017;88:9-18.
    PubMed     Text format     Abstract available


    January 2017
  17. GARD PR, Fidalgo S, Lotter I, Richardson C, et al
    Changes of renin-angiotensin system-related aminopeptidases in early stage Alzheimer's disease.
    Exp Gerontol. 2017 Jan 6. pii: S0531-5565(17)30006.
    PubMed     Text format     Abstract available


    December 2016
  18. SCARABINO D, Broggio E, Gambina G, Pelliccia F, et al
    Common variants of human TERT and TERC genes and susceptibility to sporadic Alzheimer's disease.
    Exp Gerontol. 2016 Dec 27. pii: S0531-5565(16)30423.
    PubMed     Text format     Abstract available


  19. BARRON M, Gartlon J, Dawson LA, Atkinson PJ, et al
    A state of delirium: Deciphering the effect of inflammation on tau pathology in Alzheimer's disease.
    Exp Gerontol. 2016 Dec 12. pii: S0531-5565(16)30580.
    PubMed     Text format     Abstract available


  20. NAKAGAWA T, Hasegawa Y, Uekawa K, Kim-Mitsuyama S, et al
    Chronic kidney disease accelerates cognitive impairment in a mouse model of Alzheimer's disease, through angiotensin II.
    Exp Gerontol. 2016 Dec 1. pii: S0531-5565(16)30318.
    PubMed     Text format     Abstract available


    November 2016
  21. TARANTINI S, Tran CH, Gordon GR, Ungvari Z, et al
    Impaired neurovascular coupling in aging and Alzheimer's disease: Contribution of astrocyte dysfunction and endothelial impairment to cognitive decline.
    Exp Gerontol. 2016 Nov 11. pii: S0531-5565(16)30399.
    PubMed     Text format     Abstract available


    September 2016
  22. ZHANG ZX, Zhao RP, Wang DS, Wang AN, et al
    Fuzhisan ameliorates Abeta production and tau phosphorylation in hippocampal of 11month old APP/PS1 transgenic mice: A Western blot study.
    Exp Gerontol. 2016;84:88-95.
    PubMed     Text format     Abstract available


    July 2016
  23. REDONDO MT, Beltran-Brotons JL, Reales JM, Ballesteros S, et al
    Executive functions in patients with Alzheimer's disease, type 2 diabetes mellitus patients and cognitively healthy older adults.
    Exp Gerontol. 2016;83:47-55.
    PubMed     Text format     Abstract available


    June 2016
  24. STUBBS B, Thompson T, Solmi M, Vancampfort D, et al
    Is pain sensitivity altered in people with Alzheimer's disease? A systematic review and meta-analysis of experimental pain research.
    Exp Gerontol. 2016 Jun 1. pii: S0531-5565(16)30151.
    PubMed     Text format     Abstract available


    April 2016
  25. GUO Z, Liu X, Hou H, Wei F, et al
    Abnormal degree centrality in Alzheimer's disease patients with depression: A resting-state functional magnetic resonance imaging study.
    Exp Gerontol. 2016 Apr 11. pii: S0531-5565(16)30085.
    PubMed     Text format     Abstract available


    February 2016
  26. DAOUK J, Bouzerar R, Chaarani B, Zmudka J, et al
    Use of dynamic F-fluorodeoxyglucose positron emission tomography to investigate choroid plexus function in Alzheimer's disease.
    Exp Gerontol. 2016 Feb 16. pii: S0531-5565(16)30037.
    PubMed     Text format     Abstract available


    January 2016
  27. SAVAS S, Kabaroglu C, Alpman A, Sarac F, et al
    No relationship between lipoprotein-associated phospholipase A2, proinflammatory cytokines, and neopterin in Alzheimer's disease.
    Exp Gerontol. 2016 Jan 29. pii: S0531-5565(16)30014.
    PubMed     Text format     Abstract available


    November 2015
  28. GUHRA M, Thomas C, Boedeker S, Kreisel S, et al
    Linking CSF and Cognition in Alzheimer's Disease: Reanalysis of Clinical Data.
    Exp Gerontol. 2015 Nov 13. pii: S0531-5565(15)30086.
    PubMed     Text format     Abstract available


    September 2015
  29. OTA H, Ogawa S, Ouchi Y, Akishita M, et al
    Protective effects of NMDA receptor antagonist, memantine, against senescence of PC12 cells: A possible role of nNOS and combined effects with donepezil.
    Exp Gerontol. 2015 Sep 22. pii: S0531-5565(15)30058.
    PubMed     Text format    


    August 2015
  30. WANG JZ, Wang ZH
    Senescence may mediate conversion of tau phosphorylation-induced apoptotic escape to neurodegeneration.
    Exp Gerontol. 2015;68:82-6.
    PubMed     Text format     Abstract available


    July 2015
  31. BORTOLON C, Louche A, Gely-Nargeot MC, Raffard S, et al
    Do patients suffering from Alzheimer's disease present an own-age bias in face recognition?
    Exp Gerontol. 2015 Jul 12. pii: S0531-5565(15)30012.
    PubMed     Text format     Abstract available


    June 2015
  32. VERDAGUER E, Brox S, Petrov D, Olloquequi J, et al
    Vulnerability of Calbindin, Calretinin and Parvalbumin in a transgenic/knock-in APPswe/PS1dE9 mouse model of Alzheimer disease together with disruption of hippocampal neurogenesis.
    Exp Gerontol. 2015 Jun 19. pii: S0531-5565(15)00191.
    PubMed     Text format     Abstract available


  33. LACZMANSKI L, Jakubik M, Bednarek-Tupikowska G, Rymaszewska J, et al
    Vitamin D receptor gene polymorphisms in Alzheimer's disease patients.
    Exp Gerontol. 2015;69:142-147.
    PubMed     Text format     Abstract available


  34. ZHU HX, Xue ZQ, Qiu WY, Zeng ZJ, et al
    Age-related intraneuronal accumulation of for allII-spectrin breakdown product SBDP120 in the human cerebrum is enhanced in Alzheimer's disease.
    Exp Gerontol. 2015 Jun 4. pii: S0531-5565(15)00180.
    PubMed     Text format     Abstract available


    May 2015
  35. ETTCHETO M, Petrov D, Pedros I, de Lemos L, et al
    Hypercholesterolemia and neurodegeneration. Comparison of hippocampal phenotypes in LDLr knockout and APPswe/PS1dE9 mice.
    Exp Gerontol. 2015;65:69-78.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: